GST : 09ABACA5380M1ZC
Write a Review
Our Products
Our offered Product range includes Agromir S 50/5 Tablet, Agromir 25mg Tablet, Ethamik 500mg Tablet, Prapexole 0.5 Tablet and Prapexole 0.25 Tablet.
AGROMIR S 50/5 TABLET is a clinically formulated combination of Mirabegron Extended Release 50mg and Solifenacin Succinate 5mg, designed to offer dual-action relief in the management of overactive bladder (OAB). This tablet helps improve urinary control by reducing urgency, frequency, and urge incontinencemaking it an ideal choice for patients seeking improved quality of life.
rnrnPreferred by healthcare professionals, AGROMIR S 50/5 TABLET is suitable for long-term management and demonstrates excellent tolerability. Trusted by medical distributors and bulk pharmaceutical buyers, this product supports hospitals, clinics, and pharmacies in delivering effective urological care.
Additional Information:
Packaging Details : 10X10 ALU-ALU (10 STRIPS IN 1 BOX)
PRAPEXOLE 0.5 Tablet contains Pramipexole dihydrochloride, a dopamine agonist used to treat the symptoms of Parkinson\'s disease and moderate-to-severe Restless Legs Syndrome (RLS). It works by stimulating dopamine receptors in the brain, improving movement control, reducing tremors, and alleviating discomfort associated with RLS. It is often prescribed as part of a combination therapy or on its own in early stages of Parkinsons.
rnrnKey Features:
rnrnImproves motor function
rnReduces tremors, stiffness, and slowness
rnRelieves symptoms of RLS (urge to move legs, discomfort at rest)
rnCan be used alone or with other Parkinsons medications
Each film coated tablet contains:
rnPramipexol Dihydrochloride USP Eq. to Pramipexol 0.25 mg, Excipients q.s
AGROMIR 25 Tablet is a clinically trusted treatment formulated with Mirabegron 25mg, widely prescribed for managing overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence. This beta-3 adrenergic agonist enhances bladder storage capacity without impeding normal voiding, offering improved patient compliance and quality of life.
rnrnManufactured under stringent pharmaceutical standards, AGROMIR 25 is ideal for bulk procurement by hospitals, clinics, medical distributors, and pharmaceutical wholesalers. With high demand across urology and general practice segments, this formulation meets the therapeutic needs of a growing OAB patient base.
Additional Information:
Packaging Details : 10X10 ALU-ALU ( 10 STRIP IN 1 BOX )
AGROMIR 50 Tablet is a high-quality pharmaceutical formulation containing Mirabegron 50mg, a selective beta-3 adrenergic agonist used for the effective treatment of overactive bladder (OAB). It helps improve bladder capacity and reduces frequent urination, urgency, and incontinence, offering patients improved control and quality of life.
rnrnIdeal for hospitals, clinics, and pharmacy chains, AGROMIR 50 is manufactured in compliance with GMP standards, ensuring consistent efficacy and safety. It is widely sought after by medical distributors, wholesale drug suppliers, and institutional buyers for its therapeutic reliability and high demand in urology care.
Additional Information:
Packaging Details : 10X10 ALU-ALU (10 STRIPS IN 1 BOX)
ARSULIN 0.4 Tablet contains Tamsulosin Hydrochloride 0.4 mg, a selective alpha-1 adrenergic receptor antagonist used primarily for the management of benign prostatic hyperplasia (BPH). It helps relax the muscles in the prostate and bladder neck, improving urine flow and reducing symptoms of urinary retention and discomfort.
rnKey Benefits:
rnEffectively relieves urinary symptoms associated with BPH
rnImproves urine flow and reduces bladder outlet obstruction
rnEnhances patient quality of life with minimal side effects
rnOnce-daily dosing for better compliance
rnIdeal For: Pharmaceutical distributors, urology clinics, hospital pharmacies, and bulk buyers.
ARSULIN D Tablet is a potent combination therapy designed to effectively manage symptoms of benign prostatic hyperplasia (BPH). The Tamsulosin component acts as an alpha-blocker, relaxing prostate and bladder muscles to improve urine flow, while Dutasteride reduces prostate size by inhibiting hormone conversion. This dual-action formulation provides significant relief from urinary difficulties and helps prevent disease progression.
rnKey Benefits:
rnRelieves urinary obstruction and improves flow
rnReduces enlarged prostate size for long-term management
rnDecreases risk of BPH-related complications
rnWell-tolerated with proven clinical efficacy
rnIdeal For: Urology clinics, hospital pharmacies, pharmaceutical distributors, and bulk buyers.
Mr. Kushagra Agarwal (Agrosaf Pharmaceuticals Private Limited)
F-140, Near BM Hospital, Ghatwasan,, Kamla Nagar, Agra, Uttar Pradesh - 282005, India
https://www.agrosafpharmaceuticalsindia.in
Share us via
